999765843	999765843	CD	B-NP	O
|	|	NNP	I-NP	O
WHH	WHH	NNP	I-NP	O
|	|	VBD	B-VP	O
05907477	05907477	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
616071	616071	CD	B-NP	O
|	|	CC	I-NP	O
1/24/1992	1/24/1992	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/18/1992	7/18/1992	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/24/1992	10/24/1992	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
79-year-old	79-year-old	JJ	I-NP	O
black	black	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Bistin	Bistin	NNP	I-NP	O
Wester	Wester	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
brought	bring	VBD	B-VP	O
in	in	RP	B-PRT	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
EMTs	EMT	NNS	I-NP	O
for	for	IN	B-PP	O
unresponsiveness	unresponsiveness	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
questionable	questionable	JJ	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
and	and	CC	I-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
MA	MA	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADVP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
until	until	IN	B-PP	O
approximately	approximately	RB	B-NP	O
8	8	CD	I-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
common	common	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
at	at	IN	B-PP	O
Sideplea	Sideplea	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
27	27	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
fem/pop	fem/pop	NN	I-NP	O
for	for	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
some	some	DT	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
7	7	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
NORSTOOKTRINA	NORSTOOKTRINA	NNP	B-NP	O
HOP	HOP	NNP	I-NP	O
UNIVERSITY	UNIVERSITY	NNP	I-NP	O
OF	OF	IN	B-PP	O
HEALTH	HEALTH	NNP	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infec	infec	NN	I-NP	O
-	-	HYPH	B-NP	O
tion	tion	NN	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
pneumovax	pneumovax	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
28	28	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
recurrently	recurrently	RB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
DAUTE	DAUTE	NNP	B-NP	O
ONTKEEAR	ONTKEEAR	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
for	for	IN	B-PP	O
coughs	cough	NNS	B-NP	O
and	and	CC	I-NP	O
colds	cold	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
25	25	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Landutchess	Landutchess	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
purulent	purulent	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
and	and	CC	I-NP	O
inhalers	inhaler	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Cefotetan	Cefotetan	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
steroids	steroid	NNS	I-NP	O
for	for	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
airways	airway	NNS	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
improved	improve	VBD	B-VP	O
slowly	slowly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
steadily	steadily	RB	I-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-NP	O
lethargy	lethargy	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
sick	sick	JJ	I-NP	O
feeling	feeling	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
cold	cold	JJ	B-ADJP	O
and	and	CC	O	O
clammy	clammy	NN	B-NP	O
and	and	CC	O	O
called	call	VBD	B-VP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

Approximately	Approximately	RB	B-NP	O
15	15	CD	I-NP	O
minutes	minute	NNS	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
and	and	CC	O	O
EMTs	EMT	NNS	B-NP	O
were	be	VBD	B-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-NP	O
,	,	,	I-NP	O
diahporetic	diahporetic	JJ	I-NP	O
and	and	CC	I-NP	O
nonverbal	nonverbal	JJ	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
20s	20s	CD	I-NP	O
and	and	CC	O	O
EKG	EKG	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
complete	complete	JJ	B-NP	O
heart	heart	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Atropine	Atropine	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
field	field	NN	I-NP	O
and	and	CC	O	O
brought	bring	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Waltwhidverstiicsonacot	Waltwhidverstiicsonacot	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
20	20	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
arrest	arrest	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
escaped	escape	VBN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
external	external	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
paced	pace	VBN	I-VP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
calcium	calcium	NN	B-NP	O
and	and	CC	O	O
resuscitated	resuscitate	VBD	B-VP	O
with	with	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
transvenous	transvenous	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
captured	capture	VBN	B-VP	O
effectively	effectively	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
ing	ing	VBG	B-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bicarb	bicarb	NN	I-NP	O
was	be	VBD	B-VP	O
eight	eight	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
were	be	VBD	B-VP	O
48	48	CD	B-NP	O
and	and	CC	I-NP	O
2.3	2.3	CD	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
CK	CK	NN	I-NP	O
was	be	VBD	B-VP	O
28	28	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
oriing	orie	VBG	I-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bicarb	bicarb	NN	I-NP	O
was	be	VBD	B-VP	O
eight	eight	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
were	be	VBD	B-VP	O
48	48	CD	B-NP	O
and	and	CC	I-NP	O
2.3	2.3	CD	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
CK	CK	NN	I-NP	O
was	be	VBD	B-VP	O
28	28	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
oriing	orie	VBG	I-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bicarb	bicarb	NN	I-NP	O
was	be	VBD	B-VP	O
eight	eight	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
were	be	VBD	B-VP	O
48	48	CD	B-NP	O
and	and	CC	I-NP	O
2.3	2.3	CD	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
CK	CK	NN	I-NP	O
was	be	VBD	B-VP	O
28	28	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
oriing	orie	VBG	I-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bicarb	bicarb	NN	I-NP	O
was	be	VBD	B-VP	O
eight	eight	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
were	be	VBD	B-VP	O
48	48	CD	B-NP	O
and	and	CC	I-NP	O
2.3	2.3	CD	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
CK	CK	NN	I-NP	O
was	be	VBD	B-VP	O
28	28	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
originally	originally	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
insulin	insulin	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
including	include	VBG	B-PP	O
Ceftriaxone	Ceftriaxone	NN	B-NP	O
,	,	,	I-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
Gentamicin	Gentamicin	NN	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
because	because	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
NICU	NICU	NN	I-NP	B-protein
beds	bed	VBZ	B-VP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

Allergies	Allergy	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
or	or	CC	I-VP	O
drink	drink	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
living	live	VBG	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
66	66	CD	B-NP	O
grand	grand	JJ	I-NP	O
-	-	HYPH	I-NP	O
children	child	NNS	I-NP	O
and	and	CC	O	O
30	30	CD	B-NP	O
great	great	JJ	I-NP	O
grandchildren	grandchild	NNS	I-NP	O
.	.	.	O	O

Medications	Medication	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBD	B-VP	O
Verapamil	Verapamil	NNP	B-NP	O
40	40	CD	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
insulin	insulin	NN	B-NP	O
30	30	CD	B-NP	O
units	unit	NNS	I-NP	O
NPH	NPH	NN	B-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Bactrim	Bactrim	NNP	B-NP	O
DS	DS	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
Ventolin	Ventolin	NN	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NN	I-NP	O
inhalers	inhaler	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
rotator	rotator	NN	I-NP	O
cuff	cuff	NN	I-NP	O
injuries	injury	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
femoral	femoral	JJ	I-NP	O
and	and	CC	I-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
procedure	procedure	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	IN	B-PP	O
and	and	CC	O	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
globulin	globulin	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
unit	unit	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
IV	IV	CD	B-NP	O
insulin	insulin	NN	I-NP	O
started	start	VBD	B-VP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
diabetic	diabetic	JJ	I-NP	O
ketoacidosis	ketoacidosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
sinus	sinus	NN	I-NP	O
arrest	arrest	NN	I-NP	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
metabolic	metabolic	JJ	B-ADJP	O
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
diabetic	diabetic	JJ	I-NP	O
ketoaci	ketoaci	AFX	I-NP	O
-	-	HYPH	I-NP	O
dosis	dosis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
Verapamil	Verapamil	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
suppressing	suppress	VBG	I-VP	O
her	her	PRP$	B-NP	O
sinus	sinus	NN	I-NP	O
node	node	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
insulin	insulin	NN	I-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
persistent	persistent	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
some	some	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
hard	hard	JJ	B-ADJP	O
to	to	TO	B-VP	O
gauge	gauge	VB	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
very	very	RB	B-NP	O
mild	mild	JJ	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
concomitant	concomitant	JJ	I-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
amylase	amylase	NN	I-NP	B-protein
and	and	CC	I-NP	O
lipase	lipase	NN	I-NP	O
to	to	TO	B-PP	O
approxi	approxi	AFX	B-NP	O
-	-	HYPH	I-NP	O
mately	mately	RB	B-NP	O
270	270	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
290	290	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
picture	picture	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
shock	shock	NN	B-NP	O
liver	liver	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
transaminases	transaminase	NNS	I-NP	I-protein
going	go	VBG	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000-2	000-2	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
range	range	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
LDH	LDH	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
000-3	000-3	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
resolved	resolve	VBD	B-VP	O
over	over	IN	B-PP	O
time	time	NN	B-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Ampicillin	Ampicillin	NN	B-NP	B-protein
,	,	,	I-NP	O
Gentamicin	Gentamicin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
source	source	NN	I-NP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
per	per	IN	B-PP	O
-	-	HYPH	B-NP	O
sisted	siste	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
but	but	CC	O	O
then	then	RB	B-ADVP	O
she	she	PRP	B-NP	O
defervesced	defervesce	VBD	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
3	3	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
after	after	IN	B-PP	O
having	have	VBG	B-VP	O
received	receive	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
and	and	CC	I-NP	O
ketosis	ketosis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
approximately	approximately	RB	B-NP	O
30-35	30-35	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
having	have	VBG	B-VP	O
received	receive	VBN	I-VP	O
steroids	steroid	NNS	B-NP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
steroids	steroid	NNS	I-NP	O
were	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
rapidly	rapidly	RB	B-ADVP	O
and	and	CC	O	O
,	,	,	O	O
once	once	RB	B-ADVP	O
steroids	steroid	NNS	B-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
requirement	requirement	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
markedly	markedly	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
20-30	20-30	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
but	but	CC	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
shaking	shaking	NN	I-NP	O
that	that	WDT	B-NP	O
responded	respond	VBD	B-VP	O
promptly	promptly	RB	B-ADVP	O
to	to	TO	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
juice	juice	NN	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
disease	disease	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
defervesced	defervesce	VBD	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
ques	que	NNS	I-NP	O
-	-	HYPH	O	O
tion	tion	NN	B-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
surrounding	surround	VBG	B-VP	O
her	her	PRP$	B-NP	O
original	original	JJ	I-NP	O
intubation	intubation	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
approximately	approximately	RB	B-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
watched	watch	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
left	left	JJ	I-NP	B-protein
gum	gum	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Exam	Exam	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
mild	mild	JJ	I-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
focal	focal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Peni	Peni	NNP	B-NP	O
-	-	HYPH	O	O
cillin	cillin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
range	range	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
bumped	bump	VBD	B-VP	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
3.0	3.0	CD	I-NP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.7	1.7	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
excellent	excellent	JJ	B-ADJP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
within	within	IN	B-PP	O
three	three	CD	B-NP	O
or	or	CC	I-NP	O
four	four	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
sinus	sinus	NN	I-NP	O
arrest	arrest	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
correc	correc	AFX	B-NP	O
-	-	HYPH	I-NP	O
tion	tion	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
metabolic	metabolic	JJ	I-NP	O
derangement	derangement	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
today	today	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Beywell	Beywell	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Nifedipine	Nifedipine	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Pepcid	Pepcid	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Clonidine	Clonidine	NN	B-NP	O
0.1	0.1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Ecotrin	Ecotrin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Albuterol	Albuterol	NN	B-NP	O
0.5	0.5	CD	I-NP	O
cc	cc	NN	I-NP	O
and	and	CC	O	O
2.5	2.5	CD	B-NP	O
cc	cc	NN	I-NP	O
normal	normal	JJ	I-NP	O
saline	saline	NN	I-NP	O
q.	q.	NN	I-NP	O
three	three	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
;	;	:	O	O
Penicillin	Penicillin	NN	B-NP	O
B	B	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
times	time	NNS	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
;	;	:	O	O
Peridex	Peridex	NNP	B-NP	O
swish	swish	VB	B-VP	O
and	and	CC	I-VP	O
swallow	swallow	VB	I-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
5	5	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
as	as	RB	B-ADVP	O
long	long	RB	I-ADVP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
takes	take	VBZ	B-VP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
800	800	CD	I-NP	O
kilocalorie	kilocalorie	NN	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
low-salt	low-salt	NN	B-NP	O
and	and	CC	I-NP	O
low-cholesterol	low-cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Diabetic	Diabetic	JJ	B-NP	O
ketoacidosis	ketoacidosis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Sinus	Sinus	NN	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SETH	SETH	NNP	B-NP	O
ELLSWORTH	ELLSWORTH	NNP	I-NP	O
MINIC	MINIC	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CO94	CO94	NNP	I-NP	O
SO232/7407	SO232/7407	NNP	I-NP	O
EMORY	EMORY	NNP	I-NP	O
RAYFORD	RAYFORD	NNP	I-NP	O
LOPICCALO	LOPICCALO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TK13	TK13	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/23/92	2/23/92	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/23/92	2/23/92	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
J385	J385	NNP	B-NP	O
Report	Report	NNP	I-NP	O
:	:	:	O	O
SO879Z267	SO879Z267	NN	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O

